Wed 8/5/2020 20:38 ET
DJIA27201.52378.101.39%TELCO169.640.970.57%GOLD2039.191.020.05%Shanghai3377.565.740.17%
S&P 5003327.7721.300.64%BANKS340.475.721.68%OIL42.190.491.16%BITCOIN11725.8636.350.31%
NASDAQ10998.4057.190.52%PHARM626.984.200.67%US/EU1.190.000.12%Futures3318.252.320.07%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - YM BioSciences - YMI   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  
From: crainiac (Rep: 4200)Date: 12/09/2012 19:59
Forum: YM BioSciences - Msg #3441Thread #673482866 (Rec: 0)
YM BioSciences Reports Phase I/II Data for JAK Inhibitor CYT387 in Myelofibrosis at ASH 2012

http://www.marketwatch.com/story/ym-biosciences-reports-phase-iii-data-for-jak-inhibitor-cyt387-in-myelofibrosis-at-ash-2012-2012-12-09-17183150

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser crainiac: Reward | Watch | IgnoreYMI: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 2020- TheLion.com, Inc.